Lindner Gregor, Ravioli Svenja
Department of Emergency Medicine, Kepler Universitätsklinikum GmbH, Johannes Kepler University, Linz, Austria; Department of Emergency Medicine, Inselspital, University of Bern, Bern, Switzerland.
Department of Emergency Medicine, Kepler Universitätsklinikum GmbH, Johannes Kepler University, Linz, Austria.
Am J Emerg Med. 2025 Aug;94:46-49. doi: 10.1016/j.ajem.2025.04.023. Epub 2025 Apr 19.
The emergence of artificial intelligence (AI) offers new opportunities for applications in emergency medicine, including patient triage. This study evaluates the performance of the Swiss Medical Assessment System (SMASS), an AI-based decision-support tool for rapid patient assessment, in comparison with the well-established Manchester Triage System (MTS).
In this retrospective analysis, patients aged 18 years or above presenting to the Department of Emergency Medicine at Kepler University Hospital in Linz, Austria, during November and December 2024 with non-traumatic complaints were included. Each patient underwent emergency triage using MTS, conducted by a registered nurse, with SMASS applied in parallel. SMASS had no influence on clinical decision-making.
In the study period, 1021 patients were triaged with both MTS and SMASS. The mean patient age was 60 years (SD: 21), and 53 % were women. Of the patients categorized as "orange" by MTS, 19 % were classified as non-urgent by SMASS. Conversely, 28 % of the patients triaged as "green" by MTS were classified as urgent by SMASS. Additionally, 23 % of patients classified as non-urgent by SMASS required hospitalization following emergency department evaluation and treatment. Agreement between SMASS and MTS in triaging emergency patients was low as measured by a Cohen's kappa of 0.167.
In this study of patients presenting to a large tertiary-care emergency department, SMASS demonstrated considerable discrepancies in triage classification compared to MTS, with significant rates of both over- and undertriage. Further validation is necessary before integrating AI-based triage tools into routine clinical practice.
人工智能(AI)的出现为急诊医学的应用带来了新机遇,包括患者分诊。本研究评估了瑞士医学评估系统(SMASS),一种基于人工智能的用于快速患者评估的决策支持工具,与成熟的曼彻斯特分诊系统(MTS)相比的性能。
在这项回顾性分析中,纳入了2024年11月和12月期间在奥地利林茨的开普勒大学医院急诊科就诊、年龄在18岁及以上且有非创伤性主诉的患者。每位患者均由注册护士使用MTS进行急诊分诊,并同时应用SMASS。SMASS对临床决策没有影响。
在研究期间,1021例患者同时接受了MTS和SMASS分诊。患者平均年龄为60岁(标准差:21),53%为女性。在MTS分类为“橙色”的患者中,19%被SMASS分类为非紧急。相反,在MTS分诊为“绿色”的患者中,28%被SMASS分类为紧急。此外,经SMASS分类为非紧急的患者中有23%在急诊科评估和治疗后需要住院。通过Cohen's kappa值0.167衡量,SMASS和MTS在急诊患者分诊方面的一致性较低。
在这项针对大型三级护理急诊科患者的研究中,与MTS相比,SMASS在分诊分类上表现出相当大的差异,存在过度分诊和分诊不足的显著比例。在将基于人工智能的分诊工具整合到常规临床实践之前,有必要进行进一步验证。